Gómez Valenzuela, F., Wichmann, I., Suárez, F. J., Kato, S., Ossandón, E., Hermoso, M., . . . Cuello, M. A. (2023). Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer. Web
Citación estilo ChicagoGómez Valenzuela, Fernán, Ignacio Wichmann, Felipe José Suárez, Sumie Kato, Enrique Ossandón, Marcela Hermoso, Elmer Andres Fernandez, and Mauricio A. Cuello. Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity Before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer. 2023.
Cita MLAGómez Valenzuela, Fernán, et al. Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity Before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer. 2023.